Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 8:52 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2353–2376 of 3,983 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Delirium, Cognitive Dysfunction
Interventions: Electroencephalogram (EEG); Diagnostic Test
Lead sponsor: Stanford University; Other
Eligibility: 55 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Dysmenorrhea, Dyspareunia, Endometriosis, Pelvic Pain
Interventions: ERB-041; Drug
Lead sponsor: Wyeth is now a wholly owned subsidiary of Pfizer; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 49
States / cities: Montgomery, Alabama • Chandler, Arizona • Phoenix, Arizona + 41 more

Conditions: Complication of Transplanted Liver
Interventions: Not listed
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 207 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Gestational Diabetes, Oxidative Stress, Vascular Endothelial Function
Interventions: Acetylcholine, Insulin aspart; Drug
Lead sponsor: Anna Stanhewicz, PhD; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Niemann-Pick Disease, Type C
Interventions: Parts A/B: Adrabetadex, Parts A/B: Sham Control; Drug · Other
Lead sponsor: Mandos LLC; Industry
Eligibility: 4 Years to 21 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 14
States / cities: Birmingham, Alabama • Orange, California • San Francisco, California + 11 more

Conditions: Cognitive Impairment, Schizophrenia
Interventions: Cognitive Rehabilitation Therapy (CRT) + Skill Training (SDG), Individual Computer Based Cognitive Rehabilitation (ICBCR) and Skills Training (SDG), Skills Group (SDG); Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Congestive Heart Failure
Interventions: Nesiritide, Tadalafil, Placebo, Saline load; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 21 Years to 90 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Traumatic Brain Injury, Chronic Traumatic Encephalopathy, Mild Cognitive Impairment
Interventions: Amyvid PET Scan, T807 PET scan; Drug
Lead sponsor: Samuel Gandy; Other
Eligibility: 40 Years to 85 Years · Male only
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Traumatic Brain Injury, Vision Difficulty
Interventions: neuro vision rehabilitation; Other
Lead sponsor: Hennepin Healthcare Research Institute; Other
Eligibility: 16 Years to 55 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Dry Eye Disease, Meibomian Gland Dysfunction
Interventions: IPL_RF_MGX; Device
Lead sponsor: Lumenis Be Ltd.; Industry
Eligibility: 22 Years to 85 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 2
States / cities: New York, New York • Harrisburg, North Carolina

Conditions: Left Ventricular Dysfunction, Ventricular Dysfunction, Heart Diseases, Cardiovascular Diseases
Interventions: Use of Eko DUO Electronic Stethoscope; Device
Lead sponsor: Eko Devices, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,935 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: O'Fallon, Illinois • Springfield, Illinois

Conditions: Coronary Atherosclerosis, Endothelial Dysfunction, Coronary Small Vessel Disease
Interventions: LipiScan/LipiScan IVUS; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Major Depressive Disorder, Apathy
Interventions: Targeted Cognitive Training Intervention, General Cognitive Training Intervention; Behavioral
Lead sponsor: AdventHealth; Other
Eligibility: 60 Years and older
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Aging, Endothelial Dysfunction, Senescence
Interventions: COMP-4; Dietary Supplement
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 39 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Erectile Dysfunction, Overactive Bladder, Urinary Incontinence
Interventions: Mirabegron; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 70 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: DOCK8 Deficiency
Interventions: Reduced-intensity hematopoietic stem cell, Fludarabine(Fludara, Berlex Laboratories), Cyclophosphamide(CTX, Cytoxan), Total Body Irradiation (TBI), Busulfan (Busulfex), Donor peripheral blood stem cell mobiliation and collection, Bone Marrow Harvest Procedure; Procedure · Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 4 Years to 120 Years
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2028
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Postural Orthostatic Tachycardia Syndrome (POTS), Dysautonomia, Orthostatic Intolerance, Autonomic Nervous System Diseases
Interventions: Guanfacine (GFC), Cromolyn Sodium, Placebo; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Heart Failure, Diastolic
Interventions: transcutaneous vagus nerve stimulation; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 90 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: HIV Infections
Interventions: Capsaicin Dermal Patch; Drug
Lead sponsor: NeurogesX; Industry
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 3
States / cities: West Hollywood, California • New York, New York • Portland, Oregon

Conditions: Advanced Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Liver, Metastatic Malignant Solid Neoplasm, Unresectable Solid Neoplasm
Interventions: Trametinib; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2024
U.S. locations: 8
States / cities: Sacramento, California • Tampa, Florida • Chicago, Illinois + 5 more

Conditions: Right Ventricular Dysfunction, Stroke Volume Index, Longitudinal Heart Strain
Interventions: Not listed
Lead sponsor: Tufts Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Autistic Disorder, Constipation, Gastrointestinal Diseases
Interventions: Treatment of Functional Constipation by; Other
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 5 Years to 17 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 2
States / cities: Los Angeles, California • Santa Ana, California

Conditions: Heart; Dysfunction Postoperative, Cardiac Surgery, Genetic Predisposition to Disease, Atrial Fibrillation, Myocardial Infarction, Heart Failure
Interventions: Not listed
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 20 Years to 90 Years
Enrollment: 4,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2030
U.S. locations: 3
States / cities: Boston, Massachusetts • Dallas, Texas • Houston, Texas

Conditions: Alzheimer Disease, Mild Cognitive Impairment, Dementia, Cognitive Decline, Cognitive Impairment, Memory Impairment
Interventions: PrecivityAD2(TM) blood test; Other
Lead sponsor: C2N Diagnostics; Industry
Eligibility: 55 Years and older
Enrollment: 400 participants
Timeline: 2023 – 2025
U.S. locations: 9
States / cities: San Francisco, California • Santa Monica, California • Park Ridge, Illinois + 6 more

Search by objective public record fields.

Stanford-Lucidify EEG Delirium Study

Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women

Genetic Predisposition-Chronic Nephrotoxicity From CI-Liver Transplant Recipients-Potential Correlation-Urinary Biomarkers

Role of NADPH Oxidase in Microvascular Dysfunction Following GDM

VTS-270 to Treat Niemann-Pick Type C1 (NPC1) Disease

Cognitive Rehabilitation in Schizophrenia

Tadalafil and Nesiritide as Therapy in Pre-clinical Heart Failure

Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury

Neuroimaging and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury

Feasibility of IPL Combined With RF for Treatment of DED Due to MGD

Low Ejection Fraction in Single Lead ECG

Assessment of Coronary Plaque Composition

Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics

COMP-4 Supplementation and Brachial Artery FMD

Mirabegron For Erectile Dysfunction

Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency

Guanfacine and Cromolyn Sodium for POTS: The DBPOTS Trial

Noninvasive Neuromodulation to Reserve Diastolic Dysfunction

Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated Neuropathy

Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction

Relationship Between Strain and Stroke Volume in Cardiac Surgery

Impact of Improving Gastrointestinal Symptoms on Autism Symptoms and Oxidative Stress

Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey